Addressing the Unmet Need for Diagnosing Respiratory Distress
Respiratory Motion, Inc., focuses on the development and commercialization of innovative medical devices to monitor respiratory variation. RMI's initial device, the ExSpiron, is designed to be a leading indicator of respiratory distress and collapse. Current technologies provide little predictive value resulting in extended and costly hospital stays due to respiratory failure.
Much like EKGs provide physicians advance warning of cardiac arrest, the ExSpiron can provide the new vital sign that physicians need to anticipate and prevent respiratory distress.